Related Experiment Videos
[RNA interference and its possible use in cancer therapy]
Slimane Ait-Si-Ali1, Valentina Guasconi, Annick Harel-Bellan
1UPR 9079 CNRS, Labellisée Ligue nationale contre le cancer, Institut André-Lwoff, Villejuif, France. aitsiali@vjf.cnrs.fr
Bulletin Du Cancer
|February 21, 2004
Summary
Post-transcriptional gene silencing (PTGS), also known as RNA interference (RNAi), is a key mechanism for controlling gene expression in plants and animals. This technology offers promising applications for gene therapy and understanding human gene functions.
Area of Science:
- Molecular Biology
- Genetics
Context:
- Post-transcriptional gene silencing (PTGS), or RNA interference (RNAi), is a conserved biological mechanism. Initially observed in plants, it is now recognized in both plant and animal kingdoms. PTGS plays crucial roles in natural defense systems, including viral defense and transposon silencing.
- The advent of RNA interference (RNAi) technology, utilizing small double-stranded RNA (dsRNA or siRNA), has revolutionized gene expression studies. This technique allows for the targeted knockdown of specific gene expression in mammalian cells.
Purpose:
- To explore the potential of RNA interference (RNAi) technology for therapeutic applications in humans. Specifically, to investigate its use in selectively inhibiting the expression of disease-associated genes.
- To leverage RNAi technology for systematic functional genomics research. The goal is to decipher the functions and interactions of the vast number of genes within the human genome, most of which remain uncharacterized.
Summary:
- RNA interference (RNAi) is a powerful gene silencing mechanism found in both plants and animals, involved in defense against viruses and transposons.
- RNAi technology, using small interfering RNAs (siRNAs), enables targeted gene knockdown in mammalian cells, offering potential for treating human diseases by inhibiting specific genes.
- The application of RNAi is expanding to systematically study the functions and interactions of the approximately 40,000 protein-coding genes in the human genome.
Impact:
- RNAi technology holds significant promise for developing novel therapeutic strategies for human diseases by enabling the targeted inhibition of disease-causing genes.
- RNAi provides a powerful tool for functional genomics, facilitating the systematic deciphering of gene functions and interactions within the complex human genome.
- The broader understanding of gene function through RNAi can accelerate biological research and the discovery of new drug targets.